MEDICAL SERVICES

Departments

Programs

Languages

  • English

CERTIFICATIONS

  • American Board of Dermatology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Concha JSS, Patsatsi A, Marshak-Rothstein A, Liu ML, Sinha AA, Lee LA, Merola JF, Jabbari A, Gudjonsson JE, Chasset F, Jarrett P, Chong B, Arkin L, Fernandez AP, Caproni M, Greenberg SA, Kim HJ, Pearson DR, Femia A, Vleugels RA, Fiorentino D, Fujimoto M, Wenzel J, Werth VP. Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations. J Invest Dermatol. 2018 Sep 19. View abstract
  2. Shi CR, Katz JT, Vleugels RA, Nambudiri VE. Dermatology education in internal medicine residency programs: A nationwide survey of program directors. J Am Acad Dermatol. 2018 May 15. View abstract
  3. Tong LX, Nambudiri VE, Vleugels RA. Dermatology Subspecialty Clinic for Patients with Connective Tissue Disease Impacts Diagnosis and Treatment: A Single-Center, Retrospective Analysis. J Am Acad Dermatol. 2018 Apr 21. View abstract
  4. Song P, Fett NM, Lin J, Merola JF, Costner M, Vleugels RA. Lack of response to intravenous sodium thiosulfate in three cases of extensive connective tissue disease-associated calcinosis cutis. Br J Dermatol. 2018 Jun; 178(6):1412-1415. View abstract
  5. Pinard J, Patel M, Granter SR, Vleugels RA, Merola JF. Subacute Cutaneous Lupus Erythematosus Induced by Palbociclib. J Cutan Med Surg. 2018 May/Jun; 22(3):341-343. View abstract
  6. Pinard J, Vleugels RA, Joyce C, Merola JF, Patel M. Hidradenitis suppurativa burden of disease tool: Pilot testing of a disease-specific quality of life questionnaire. J Am Acad Dermatol. 2018 01; 78(1):215-217.e2. View abstract
  7. Kurtzman DJB, Vleugels RA. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol. 2018 04; 78(4):776-785. View abstract
  8. Mazori DR, Femia AN, Vleugels RA. Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment. Curr Rheumatol Rep. 2017 Nov 04; 19(12):74. View abstract
  9. Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis. JAMA Dermatol. 2017 Nov 01; 153(11):1147-1157. View abstract
  10. Shi CR, Olbricht S, Vleugels RA, Nambudiri VE. Sex and leadership in academic dermatology: A nationwide survey. J Am Acad Dermatol. 2017 10; 77(4):782-784. View abstract
  11. Fruchter R, Kurtzman DJB, Patel M, Merola J, Franks AG, Vleugels RA, Femia AN. Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus. JAMA Dermatol. 2017 Sep 01; 153(9):937-939. View abstract
  12. Kurtzman DJB, Weinblatt M, Vleugels RA. Antimelanoma Differentiation-associated Gene 5 Dermatomyositis. J Rheumatol. 2017 06; 44(6):850-851. View abstract
  13. Bae GH, Kurtzman D, Granter SR, Vleugels RA, Nambudiri VE. Asymptomatic papules after breast cancer treatment. J Am Acad Dermatol. 2017 May; 76(5):e157-e158. View abstract
  14. Bae GH, Kurtzman D, Granter SR, Vleugels RA, Nambudiri VE. Asymptomatic papules after breast cancer treatment. J Am Acad Dermatol. 2017 May; 76(5):e157-e158. View abstract
  15. Pinard J, Vleugels RA, Kurtzman DJ, Devlin PM, Patel M. Novel Application of High-Dose-Rate Brachytherapy for Severe, Recalcitrant Acrodermatitis Continua of Hallopeau. JAMA Dermatol. 2017 04 01; 153(4):331-332. View abstract
  16. Huard C, Gullà SV, Bennett DV, Coyle AJ, Vleugels RA, Greenberg SA. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon ß in dermatomyositis. Br J Dermatol. 2017 May; 176(5):1224-1230. View abstract
  17. Kurtzman DJ, Vleugels RA. Expanding the use of the Cutaneous Dermatomyositis Area and Severity Index (CDASI) to nondermatologists. Br J Dermatol. 2017 02; 176(2):296-297. View abstract
  18. Kurtzman DJ, Wright NA, Patel M, Vleugels RA. Segmental stiff skin syndrome (SSS): Two additional cases with a positive response to mycophenolate mofetil and physical therapy. J Am Acad Dermatol. 2016 Dec; 75(6):e237-e239. View abstract
  19. Fruchter R, Kurtzman DJB, Mazori DR, Wright NA, Patel M, Vleugels RA, Femia AN. Characteristics and treatment of postirradiation morphea: A retrospective multicenter analysis. J Am Acad Dermatol. 2017 Jan; 76(1):19-21. View abstract
  20. Kurtzman DJ, Ho A, Wright NA, Rubenstein MH, Vleugels RA. Unilateral Gottron Papules in a Patient Following a Stroke: Clinical Insights Into the Disease Mechanisms and Pathophysiology of Cutaneous Dermatomyositis. JAMA Dermatol. 2016 09 01; 152(9):1062-3. View abstract
  21. Kurtzman DJ, Wright NA, Lin J, Femia AN, Merola JF, Patel M, Vleugels RA. Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment. JAMA Dermatol. 2016 08 01; 152(8):944-5. View abstract
  22. Nahmias Z, Nambudiri VE, Vleugels RA. Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions. J Am Acad Dermatol. 2016 Jul; 75(1):210-2. View abstract
  23. Nambudiri VE, Qureshi AA, Vleugels RA. Sharps injuries among US dermatology trainees: A cross-sectional study. J Am Acad Dermatol. 2016 Apr; 74(4):756-8. View abstract
  24. Mazori DR, Wright NA, Patel M, Liu SW, Ramachandran SM, Franks AG, Vleugels RA, Femia AN. Characteristics and treatment of adult-onset linear morphea: A retrospective cohort study of 61 patients at 3 tertiary care centers. J Am Acad Dermatol. 2016 Mar; 74(3):577-9. View abstract
  25. Song JS, Halim K, Vleugels RA, Merola JF. Dapsone for treatment of erythema nodosum. Dermatol Online J. 2016 Feb 17; 22(2). View abstract
  26. Timerman D, Devlin PM, Nambudiri VE, Wright NA, Vleugels RA, Clark RA, Kupper TS, Merola JF, Patel M. Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis. Clin Exp Dermatol. 2016 Jul; 41(5):498-501. View abstract
  27. Lam C, Liu SW, Townsend HB, Femia AN, Qureshi AA, Vleugels RA. Development and Pilot Testing of the Cutaneous Lupus Screening Tool. JAMA Dermatol. 2016 Jan; 152(1):60-6. View abstract
  28. Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA. Epidemiology and Treatment of Eosinophilic Fasciitis: An Analysis of 63 Patients From 3 Tertiary Care Centers. JAMA Dermatol. 2016 Jan; 152(1):97-9. View abstract
  29. Goddard AL, Vleugels RA, LeBoeuf NR, O'Farrell DA, Cormack RA, Hansen JL, Kupper TS, Devlin PM. Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy. JAMA Dermatol. 2015 Dec 01; 151(12):1354-1357. View abstract
  30. Wright NA, Vleugels RA, Callen JP. Cutaneous dermatomyositis in the era of biologicals. Semin Immunopathol. 2016 Jan; 38(1):113-21. View abstract
  31. Patel M, Cohen JM, Wright NA, Merola JF, Qureshi AA, Vleugels RA. Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): experience of a tertiary medical center. J Am Acad Dermatol. 2015 Oct; 73(4):701-2. View abstract
  32. Winterfield L, Vleugels RA, Park KK. The Value of the Black Box Warning in Dermatology. J Drugs Dermatol. 2015 Jul; 14(7):660-6. View abstract
  33. Hu L, Alexander C, Velez NF, Yang C, Canales AL, Liu S, Vleugels RA. Severe Tacrolimus-Induced Granulomatous Rosacea Recalcitrant to Oral Tetracyclines. J Drugs Dermatol. 2015 Jun; 14(6):628-30. View abstract
  34. Ogbechie OA, Nambudiri VE, Vleugels RA. Teledermatology perception differences between urban primary care physicians and dermatologists. JAMA Dermatol. 2015 Mar; 151(3):339-40. View abstract
  35. Sheik Ali S, Goddard AL, Luke JJ, Donahue H, Todd DJ, Werchniak A, Vleugels RA. Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade. JAMA Dermatol. 2015 Feb; 151(2):195-9. View abstract
  36. Ogbechie OA, Eastham AB, Vleugels RA. Tense bullae on the palms and soles. JAMA Dermatol. 2015 Jan; 151(1):99-100. View abstract
  37. Patel M, Femia AN, Eastham AB, Lin J, Canales AL, Vleugels RA. Facial erythromelalgia: a rare entity to consider in the differential diagnosis of connective tissue diseases. J Am Acad Dermatol. 2014 Dec; 71(6):e250-1. View abstract
  38. Nambudiri VE, Vleugels RA, Laga AC, Goldberg LJ. Clinicopathologic lessons in distinguishing cicatricial alopecia: 7 cases of lichen planopilaris misdiagnosed as discoid lupus. J Am Acad Dermatol. 2014 Oct; 71(4):e135-8. View abstract
  39. Eastham AB, Femia AN, Velez NF, Smith HP, Vleugels RA. Paraproteinemia-associated scleredema treated successfully with intravenous immunoglobulin. JAMA Dermatol. 2014 Jul; 150(7):788-9. View abstract
  40. Eastham AB, Hornick J, Gaviola G, Vleugels RA. A 52-year-old woman with subcutaneous nodules and abdominal pain. Clin Exp Dermatol. 2014 Jun; 39(4):547-9. View abstract
  41. Wu S, Han J, Vleugels RA, Puett R, Laden F, Hunter DJ, Qureshi AA. Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women. Br J Cancer. 2014 Apr 02; 110(7):1855-61. View abstract
  42. Nambudiri VE, Newman LR, Haynes HA, Schur P, Vleugels RA. Creation of a novel, interdisciplinary, multisite clerkship: "understanding lupus". Acad Med. 2014 Mar; 89(3):404-9. View abstract
  43. Eastham AB, Vleugels RA. Cutaneous lupus erythematosus. JAMA Dermatol. 2014 Mar; 150(3):344. View abstract
  44. Eastham AB, Femia AN, Qureshi A, Vleugels RA. Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center. JAMA Dermatol. 2014 Jan; 150(1):92-4. View abstract
  45. Roh EK, Vleugels RA, Hoang MP. Case records of the Massachusetts General Hospital. Case 39-2013. A 57-year-old woman with painful bullous skin lesions. N Engl J Med. 2013 Dec 19; 369(25):2438-49. View abstract
  46. Zhou X, Velez NF, Farsani T, Tsiaras W, Laga AC, Werchniak AE, Vleugels RA. Multiple tense bullae localized to the right breast in a woman in her seventies. JAMA Dermatol. 2013 Dec; 149(12):1427-8. View abstract
  47. Eastham AB, Liang CA, Femia AN, Lee TC, Vleugels RA, Merola JF. Lupus erythematosus panniculitis-induced facial atrophy: effective treatment with poly-L-lactic acid and hyaluronic acid dermal fillers. J Am Acad Dermatol. 2013 Nov; 69(5):e260-e262. View abstract
  48. Frankel HC, Sharon VR, Vleugels RA, Merola JF, Qureshi AA. Lower-dose thalidomide therapy effectively treats cutaneous lupus erythematosus but is limited by neuropathic toxicity. Int J Dermatol. 2013 Nov; 52(11):1407-9. View abstract
  49. Femia AN, Eastham AB, Lam C, Merola JF, Qureshi AA, Vleugels RA. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center. J Am Acad Dermatol. 2013 Oct; 69(4):654-7. View abstract
  50. Nguyen K, Vleugels RA, Velez NF, Merola JF, Qureshi AA. Psoriasiform reactions to anti-tumor necrosis factor a therapy. J Clin Rheumatol. 2013 Oct; 19(7):377-81. View abstract
  51. Liu SW, Velez NF, Lam C, Femia A, Granter SR, Townsend HB, Vleugels RA. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis. JAMA Dermatol. 2013 Oct; 149(10):1204-8. View abstract
  52. Femia AN, Vleugels RA, Callen JP. Cutaneous dermatomyositis: an updated review of treatment options and internal associations. Am J Clin Dermatol. 2013 Aug; 14(4):291-313. View abstract
  53. Click JW, Qureshi AA, Vleugels RA. Methotrexate for the treatment of cutaneous dermatomyositis. J Am Acad Dermatol. 2013 Jun; 68(6):1043-5. View abstract
  54. Lam C, Vleugels RA. Images in clinical medicine. Epidermolysis bullosa acquisita. N Engl J Med. 2013 Mar 28; 368(13):e17. View abstract
  55. Eastham AB, Velez NF, Chesebro AL, Townsend HB, Vleugels RA. Diffuse dystrophic calcinosis cutis of the scalp in a patient with scalp discoid lupus erythematosus and systemic lupus erythematosus. JAMA Dermatol. 2013 Feb; 149(2):246-8. View abstract
  56. Velez NF, Ishizawar RC, Dellaripa PF, Saavedra AP, Laga AC, Murphy GF, Fisher DC, Kupper TS, Vleugels RA. Full facial edema: a novel presentation of subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol. 2012 Sep 01; 30(25):e233-6. View abstract
  57. Girouard SD, Velez NF, Penson RT, Massarotti EM, Vleugels RA. Panniculitis associated with dermatomyositis and recurrent ovarian cancer. Arch Dermatol. 2012 Jun; 148(6):740-4. View abstract
  58. Velez NF, Callen JP, Vleugels RA. Calcinosis cutis: an additional therapy to consider. J Am Acad Dermatol. 2012 Jun; 66(6):1004-5; author reply 1005. View abstract
  59. Gropper AB, Girouard SD, Hojman LP, Huang SJ, Qian X, Murphy GF, Vleugels RA. Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature. J Cutan Pathol. 2012 May; 39(5):526-34. View abstract
  60. Lam C, Vleugels RA. Management of cutaneous dermatomyositis. Dermatol Ther. 2012 Mar-Apr; 25(2):112-34. View abstract
  61. Halvorsen JA, Vleugels RA, Bjertness E, Lien L. A population-based study of acne and body mass index in adolescents. Arch Dermatol. 2012 Jan; 148(1):131-2. View abstract
  62. Vedvyas C, Winterfield LS, Vleugels RA. Calciphylaxis: a systematic review of existing and emerging therapies. J Am Acad Dermatol. 2012 Dec; 67(6):e253-60. View abstract
  63. Vleugels RA. Identifying when therapy for one skin disease is likely to exacerbate another skin condition. Arch Dermatol. 2011 Jul; 147(7):836. View abstract
  64. Doyle LA, Sperling LC, Baksh S, Lackey J, Thomas B, Vleugels RA, Qureshi AA, Velazquez EF. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-a therapy: a novel cause of noncicatricial alopecia. Am J Dermatopathol. 2011 Apr; 33(2):161-6. View abstract
  65. Badisco L, Marchal E, Van Wielendaele P, Verlinden H, Vleugels R, Vanden Broeck J. RNA interference of insulin-related peptide and neuroparsins affects vitellogenesis in the desert locust Schistocerca gregaria. Peptides. 2011 Mar; 32(3):573-80. View abstract
  66. Laga AC, Vleugels RA, Qureshi AA, Velazquez EF. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-a inhibitor therapy. A study of 16 biopsies. Am J Dermatopathol. 2010 Aug; 32(6):568-73. View abstract
  67. Ross JJ, Saavedra A, Vleugels RA, Liu A, Castells MC. Interactive medical case. A rash hypothesis. N Engl J Med. 2010 Jun 17; 362(24):e69. View abstract
  68. Verlinden H, Vleugels R, Marchal E, Badisco L, Pflüger HJ, Blenau W, Broeck JV. The role of octopamine in locusts and other arthropods. J Insect Physiol. 2010 Aug; 56(8):854-67. View abstract
  69. Verlinden H, Vleugels R, Marchal E, Badisco L, Tobback J, Pflüger HJ, Blenau W, Vanden Broeck J. The cloning, phylogenetic relationship and distribution pattern of two new putative GPCR-type octopamine receptors in the desert locust (Schistocerca gregaria). J Insect Physiol. 2010 Aug; 56(8):868-75. View abstract
  70. Eshaghian A, Vleugels RA, Canter JA, McDonald MA, Stasko T, Sligh JE. Mitochondrial DNA deletions serve as biomarkers of aging in the skin, but are typically absent in nonmelanoma skin cancers. J Invest Dermatol. 2006 Feb; 126(2):336-44. View abstract
  71. Girald-Rosa W, Vleugels RA, Musiek AC, Sligh JE. High-throughput mitochondrial genome screening method for nonmelanoma skin cancer using multiplexed temperature gradient capillary electrophoresis. Clin Chem. 2005 Feb; 51(2):305-11. View abstract